Beta-Blocker Use and Outcomes Among Hospitalized Heart Failure Patients

Journal of the American College of Cardiology

Volumn 47, Issue 12, 2006, Pages 2462-2469

  Butler, Javed ^a   Young, James B ^b   Abraham, William T ^c   Bourge, Robert C ^d   Adams Jr , Kirkwood F ^e   Clare, Robert ^f   O'Connor, Christopher ^g  

^a VANDERBILT UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL;

ADULT; AGED; AORTA BALLOON; ARTICLE; ARTIFICIAL VENTILATION; BREATHING RATE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG SUBSTITUTION; DRUG USE; EVALUATION; FEMALE; FOLLOW UP; HEART BEAT; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MORTALITY; PRIORITY JOURNAL; RESUSCITATION; RISK; RISK REDUCTION; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADRENERGIC BETA-ANTAGONISTS; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED;

EID: 33744967948     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.03.030     Document Type: Article

References (16)

1. Bristow M.R., Gilbert E.M., Abraham W.T., et al., MOCHA Investigators. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 94 (1996) 2807-2816
2. The MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
3. Packer M., Coats A.J., Fowler M.B., et al., Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 (2001) 1651-1658
4. Packer M., Bristow M.R., Cohn J.N., et al., U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
5. The CIBIS-II Investigators. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II). a randomized trial. Lancet 353 (1999) 9-13
6. Gattis W.A., O'Connor C.M., Gallup D.S., et al., IMPACT-HF Investigators and Coordinators. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J Am Coll Cardiol 43 (2004) 1534-1541
7. Tarantini L., Cioffi G., Opasich C., et al. Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure. an effective strategy for the implementation of beta-blockade in heart failure. Ital Heart J 5 (2004) 441-449
8. The ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness. the ESCAPE trial. JAMA 294 (2005) 1625-1633
9. Gattis W.A., O'Connor C.M., Leimberger J.D., et al. Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure. Am J Cardiol 91 (2003) 169-174
10. O'Connor C.M., Gattis W.A., Zannad F., et al. Beta-blocker therapy in advanced heart failure. clinical characteristics and long-term outcomes. Eur J Heart Fail 1 (1999) 81-88
11. Butler J., Arbogast P.G., Daugherty J., et al. Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge. J Am Coll Cardiol 43 (2004) 2036-2043
12. Butler J., Argobast P.G., BeLue R., et al. Outpatient adherence to beta-blocker therapy after acute myocardial infarction. J Am Coll Cardiol 40 (2002) 1589-1595
13. JCAHO Overview of Heart Failure Core Measure Set. Available at: http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/Heart+Failure+C. Accessed April 17, 2006.
14. Quality Improvement Organizations: Statement of Work. Available at: http://cms.hhs.gov/qio/2.asp. Accessed June 8, 2005.
15. American Heart Association. Get With The Guidelines. Available at: http://www.americanheart.org/presenter.jhtml?identifier=1165. Accessed June 8, 2003.
16. American College of Cardiology. Guidelines Applied in Practice. Available at: http://www.acc.org/gap/gap.htm. Accessed June 8, 2005.